Structure-Activity Relationships and Drug Design
Pharmacodynamic Models: Overview
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacokinetic–Pharmacodynamic Relationship: Problems
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 16, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Xialan Dong1, Jerry O Ebalunode, Sung Jin Cho
1Department of Pharmaceutical Sciences, BRITE Institute, North Carolina Central University, Durham, North Carolina 27707, USA.
A new structure-based multimode QSAR method uses protein structure to characterize ligands for improved drug discovery. This approach offers superior predictive models for molecular activity compared to existing QSAR techniques.
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: